Completed NA INTERVENTIONAL 2-arm NCT05243160

Medication Reviews in Severe Mental Illness

Implementing Medication Reviews Through Interdisciplinary Dialogue in Patients With Coexisting Diabetes and Mental Illness

Sponsor: Psychiatric Research Unit, Region Zealand, Denmark

Conditions Bipolar Disorder Diabetes Major Depressive Disorder Metabolic Syndrome Psychosis Psychotic Disorders Schizophrenia Severe Mental Disorder

Interventions medication review

Updated 5 times since 2022 Last updated: Aug 29, 2024 Started: Mar 11, 2022 Primary completion: Oct 27, 2023 Completion: Oct 27, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bipolar Disorder and Diabetes and is currently completed. Psychiatric Research Unit, Region Zealand, Denmark leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Oct 2024 — Present [monthly]

Completed NA
Sep 2024 — Oct 2024 [monthly]

Completed NA

Status: Unknown → Completed
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Mar 2022 — Feb 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Psychiatric Research Unit, Region Zealand, Denmark
Region Zealand
Steno Diabetes Center Sjaelland

Data source: Psychiatric Research Unit, Region Zealand, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Slagelse, Denmark